The uncertain correlation of ANCAs in patients with lupus nephritis and crescents, an experience from Chinese centers
2024

The Role of ANCAs in Crescentic Lupus Nephritis

Sample size: 46 publication Evidence: moderate

Author Information

Author(s): Zhang Qiong, Zhou Fei, Zhao Yan, Luo Congjuan, Luo Yankun, Zhou Yun

Primary Institution: Department of Nephrology, Fifth Hospital of Shanxi Medical University

Hypothesis

Is ANCA-positive serology in patients with lupus nephritis and crescents associated with different clinicopathologic features and outcomes?

Conclusion

Short-term follow-up showed no difference in outcomes between ANCA-positive and ANCA-negative crescentic lupus nephritis patients.

Supporting Evidence

  • 46 patients were enrolled in the study after exclusions.
  • 12 patients were ANCA-positive and 34 were ANCA-negative.
  • ANCA-negative patients had higher proteinuria and lower serum albumin levels.

Takeaway

This study looked at patients with a type of kidney disease called crescentic lupus nephritis to see if a specific antibody (ANCA) made a difference in their health outcomes, but it found that it didn't.

Methodology

A retrospective review of 658 lupus nephritis patients was conducted, with 46 patients analyzed based on ANCA positivity.

Potential Biases

The detection method for ANCAs may be nonspecific, and the study was limited to a single ethnic group.

Limitations

The study had a small sample size and a short follow-up period, which may affect the results.

Participant Demographics

The average age of participants was 33.98 years, with 9 males and 37 females.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s40620-024-02085-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication